Spiroalmotriptan is a spirocyclic indoline derivative featuring a pyrrolidine sulfonylmethyl substituent. It is characterized by a complex fused-ring structure that includes an alcohol functional group and multiple heterocyclic rings, with a molecular weight of approximately 351 Da, moderate lipophilicity, and two hydrogen bond donors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Spiroalmotriptan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-
pharmaceutical raw material
Diatrizoate meglumine
pharmaceutical raw material
Dioxybenzone
pharmaceutical raw material
Boldenone undecylenate
pharmaceutical raw material
1'-methyl-5-(pyrrolidin-1-ylsulfonylmethyl)spiro[1,2-dihydroindole-3,3'-pyrrolidine]-2-ol
LXSWXVHNXSOIPG-UHFFFAOYSA-N
CN1CCC2(C1)C(NC3=C2C=C(C=C3)CS(=O)(=O)N4CCCC4)O
Sourcing Spiroalmotriptan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.